2017
DOI: 10.1039/c6dt03856e
|View full text |Cite
|
Sign up to set email alerts
|

Hexamethylenetetramine carboxyborane: synthesis, structural characterization and CO releasing properties

Abstract: Carbon monoxide, although widely known as a toxic gas, has received great attention in the past few decades due to its promising role as a medical gas. Several classes of carbon monoxide releasing molecules (CORMs) have been synthesised with many of them having pharmacological activities under physiological conditions. Herein, we report the synthesis and structural characterization of the first example of amine carboxyborane that releases CO under physiological conditions without the aid of inducers. A represe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
23
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
6
1
1

Relationship

1
7

Authors

Journals

citations
Cited by 20 publications
(25 citation statements)
references
References 43 publications
2
23
0
Order By: Relevance
“…The stereogenic centres in the adamantane unit were assigned as C4 S and C8 R in the arbitrarily chosen asymmetric unit but crystal symmetry generates a racemic mixture. The bond lengths [C1-O1 = 1.340 (4), C1-O2 = 1.227 (4) Å ] of the carboxylic acid group are in agreement with the data for related carboxylic acids and known amine-carboxyboranes (Gavezzotti, 2008;Spielvogel et al, 1980;Vyakaranam et al, 2002;Ayudhya et al, 2017). The C-C-C bond angles of the adamantine cage fall within the expected ranges and the N1-C2 bond length at 1.504 (4) Å is comparable with previously reported values in aminoadamantane structures (Donohue & Goodman, 1967;Chacko & Zand, 1973).…”
Section: Structural Commentarysupporting
confidence: 85%
See 2 more Smart Citations
“…The stereogenic centres in the adamantane unit were assigned as C4 S and C8 R in the arbitrarily chosen asymmetric unit but crystal symmetry generates a racemic mixture. The bond lengths [C1-O1 = 1.340 (4), C1-O2 = 1.227 (4) Å ] of the carboxylic acid group are in agreement with the data for related carboxylic acids and known amine-carboxyboranes (Gavezzotti, 2008;Spielvogel et al, 1980;Vyakaranam et al, 2002;Ayudhya et al, 2017). The C-C-C bond angles of the adamantine cage fall within the expected ranges and the N1-C2 bond length at 1.504 (4) Å is comparable with previously reported values in aminoadamantane structures (Donohue & Goodman, 1967;Chacko & Zand, 1973).…”
Section: Structural Commentarysupporting
confidence: 85%
“…Assessment of available crystal structures deposited with the Cambridge Structural Database (Version 5.39; Groom et al, 2016) indicates that not all amine-carboxyboranes form dimers during crystallization. While some amine-carboxyboranes described above are dimers, others such as piperidine-carboxyborane and hexamethylenetetraminecarboxyborane do not form dimers, suggesting that the aminegroup interaction may influence the overall packing Ayudhya et al, 2017). The extended structure of (I) is shown in projection down the b-and c-axis directions in Fig.…”
Section: Supramolecular Featuresmentioning
confidence: 96%
See 1 more Smart Citation
“…Although metal carbonyls hold great promise in both laboratory and clinical investigations, 9,[11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26] the development of metal-free CORMs has recently been receiveing increasing attention. 27 In this context, boranocarbonates, 28 CO-releasing prodrugs operated in a "click and release" manner, [29][30][31] and photoresponsive organic CORMs such as 3-hydroxyavone (3-HF) derivatives, [32][33][34][35][36][37] xanthene-9-carboxylic acid, 38 BODIPY derivatives, 39 and aromatic a-diketone derivatives 40 have been developed.…”
Section: Introductionmentioning
confidence: 99%
“…1,[4][5][6][7][8][9][10] Some nonmetallic CORMs have also been developed in recent years. [12][13][14][15][16][17][18] CORMs allows convenient administration of a certain dose of CO. In addition, the potential to control the release of CO to a specific target is the major advantage of CORMs over gaseous CO as a therapeutic agent.…”
mentioning
confidence: 99%